Ping Liang, PhD

Affiliations: 
Stanford University, Palo Alto, CA 
Google:
"Ping Liang"
Mean distance: 16.04 (cluster 11)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Sun Y, Zhou J, Wang H, et al. (2022) Establishment of an induced pluripotent stem cell line (ZJULLi004-A) from a hypertrophic cardiomyopathy patient carrying MYBPC3/c.3764C>A mutation. Stem Cell Research. 64: 102898
He X, Song S, Yang P, et al. (2022) A rare radiotherapy-sensitive primitive neuroectodermal tumor with gene amplification in an adult: a case report and literature review. The Journal of International Medical Research. 50: 3000605221118704
Zhou J, Sun Y, Wang H, et al. (2022) Generation of an induced pluripotent stem cell line (ZJULLi003-A) from a hypertrophic cardiomyopathy patient carrying MYH7/c.4384G > A mutation. Stem Cell Research. 64: 102883
Guo F, Sun Y, Wang H, et al. (2022) Generation of an induced pluripotent stem cell line from a long QT syndrome patient carrying KCNH2/1956C > A mutation. Stem Cell Research. 62: 102813
Qiu H, Sun Y, Pan Z, et al. (2021) Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell-derived cardiomyocytes with a MYBPC3 mutation. Clinical and Translational Medicine. 11: e647
Yu M, Lei W, Cao J, et al. (2021) Requirements for human cardiomyocytes. Cell Proliferation. e13150
Wang X, Pan Z, Wang J, et al. (2021) Characterization of the molecular mechanisms underlying azithromycin-induced cardiotoxicity using human-induced pluripotent stem cell-derived cardiomyocytes. Clinical and Translational Medicine. 11: e549
Li X, Gao F, Wang X, et al. (2021) E2A ablation enhances proportion of nodal-like cardiomyocytes in cardiac-specific differentiation of human embryonic stem cells. Ebiomedicine. 71: 103575
Pan Z, Wang H, Wang H, et al. (2021) Generation of an induced pluripotent stem cell line from a patient carrying FBN1/c.6734 G > A mutation. Stem Cell Research. 55: 102459
Liu C, Han D, Liang P, et al. (2021) The Current Dilemma and Breakthrough of Stem Cell Therapy in Ischemic Heart Disease. Frontiers in Cell and Developmental Biology. 9: 636136
See more...